Sodium Valproate

Clinical and Electroencephalographical Classification of Epileptic Seizures

1970 • 538 citations

Epilepsy and γ-Aminobutyric Acid-Mediated Inhibition

1975 • 491 citations

EFFECTS OF DI‐n‐PROPYLACETATE, AN ANTICONVULSIVE COMPOUND, ON GABA METABOLISM¹

1969 • 394 citations

Effect of sodium n-dipropylacetate on audiogenic seizures and brain γ-aminobutyric acid level

1973 • 285 citations

Sodium Di‐N‐Propylacetate (DPA) in the Treatment of Epilepsy:A Review

1975 • 255 citations

[Pharmacodynamic properties of N-dipropylacetic acid].

1963 • 247 citations

Treatment of Generalized Epilepsies of Childhood and Adolescence with Sodium Valproate (‘Epilim’)

1977 • 193 citations

Laboratory Evaluation of Antiepileptic Drugs

1969 • 189 citations

Anticonvulsant action of ethanolamine-O-sulphate and di-n-propylacetate and the metabolism of γ-aminobutyric acid (GABA) in mice with audiogenic seizures

1976 • 175 citations

Sodium Valproate in Treatment of Epilepsy

1974 • 172 citations

Pharmacokinetics of di-n-propylacetate in epileptic patients

1975 • 142 citations

Effect of Sodium Valproate on Tardive Dyskinesia

1976 • 118 citations

The inhibitory effect of sodium n‐dipropyl acetate on the degradative enzymes of the GABA shunt

1975 • 112 citations

Effects of Anticonvulsant Drugs on the Cerebral Enzymes Metabolizing GABA

1975 • 105 citations

Dipropylacetate (Depakine®, Ergenyl®) in the Treatment of Epilepsy

1973 • 101 citations

Controlled trial of sodium valproate in severe epilepsy.

1975 • 97 citations

Concentration of Dipropylacetate in Plasma

1975 • 87 citations

Huntington's disease

1976 • 74 citations

Sodium Valproate in the Treatment of Intractable Childhood Epilepsy

1975 • 71 citations

Metabolism of branched medium chain length fatty acid. II—β-oxidation of sodium dipropylacetate in rats

1976 • 66 citations

Determination of lower fatty acids, particularly the anti-epileptic dipropyl-acetic acid, in biological materials by means of micro diffusion and gas chromatography

1973 • 61 citations

SODIUM VALPROATE IN the TREATMENT of RESISTANT EPILEPSY

1976 • 59 citations

Sodium valproate and thrombocytopenia.

1976 • 59 citations

Absorption and Distribution of Antiepileptic Drugs

1975 • 57 citations

Sodium valproate and platelet function.

1976 • 46 citations

The Treatment of Childhood Epilepsy with Sodium Valproate

1975 • 44 citations

Prevention of Febrile Convulsions with Dipropylacetate (Depakine®)

1975 • 43 citations

A DOUBLE BLIND STUDY OF THE INFLUENCE OF DIPROPYLACETATE ON BEHAVIOUR

1975 • 39 citations

Clinical trials of anti-epileptic drugs.

1971 • 37 citations

ELEVATION OF DIPHENYLHYDANTOIN and PRIMIDONE SERUM CONCENTRATION BY ADDITION OF DIPROPYLACETATE, A NEW ANTICONVULSANT DRUG

1975 • 33 citations

Regional distribution in brain and effect of cerebral mitochondrial respiration of the anticonvulsive drug n-diproylacetate

1975 • 32 citations

[Blood coagulation changes through dipropyl-acetic-acid (Ergenyl)].

1974 • 29 citations

Di-n-propylacetic acid--profile of anticonvulsant activity in mice.

1976 • 28 citations

Clinical Pharmacokinetics: A Symposium

1975 • 25 citations

[Action of dipropylacetic acid upon photosensitive Papio papio].

1971 • 24 citations

Studies on a New Anticonvulsant Drug, Sodium Dipropylacetate. Assay for Metabolites and Metabolic Pathway

1972 • 22 citations

[PHARMACODYNAMIC PROPERTIES OF 2,2-DIPROPYLACETIC ACID. 2D REPORT ON ITS ANTI-EPILEPTIC PROPERTIES].

1964 • 21 citations

Dipropylacetic Acid (Depakine®) in Experimental Epilepsy in the Alert Cat

1975 • 20 citations

Sodium valproate in chorea.

1976 • 20 citations

Klinische Erfahrungen mit einem neuen Antiepileptikum: Dipropylessigsäure

1971 • 18 citations

EXPERIENCES ON THE USE OF DIPROPYLACETATE IN THE TREATMENT OF CHILDHOOD EPILEPSY

1976 • 18 citations

[Rapid method of quantitative analysis of sodium dipropylacetate in serum or plasma].

1973 • 17 citations

The Use of Sodium Valproate in a Case of Status Epilepticus

1976 • 16 citations

The effects of n-dipropylacetate on the acquisition of conditioned behaviour with negative reinforcement in mice

1975 • 16 citations

A Clinical Note on a New Antiepileptic, ‘Depakine®’

1970 • 15 citations

Mechanisms of dyskinesia induction by 1-(3,4-dihydroxyphenyl) piperazine in the rat

1976 • 13 citations

The Experimental Approach to Alcoholism *

1975 • 13 citations

[Electroencephalographic changes in epileptic child treated by Depakene].

1968 • 11 citations

Actions and Interactions of Dipropylacetate and Penicillin on Evoked Potentials of Excised Prepiriform Cortex of Guinea Pig

1975 • 8 citations

[Influence of dipropylacetic acid on hemostasis].

1976 • 6 citations

Sodium Valproate in the Treatment of Intractable Childhood Epilepsy

1975 • 6 citations

[Treatment of refractory epilepsy with dipropyl acetate].

1973 • 6 citations

[Effect of sodium dipropylacetate on certain varieties of epileptogenic encephalopathies in infants].

1969 • 6 citations

Behandlung atypischer Absencen mit einer Succinimid-Dipropylacetat-Kombination

1975 • 5 citations

[Changes in hemostasis during epilespy treatment using dipropyl acetate. Extended study].

1976 • 5 citations

[Pharmacokinetic study of sodium di-n-propylacetate (usual tablet and enteric coated tablet with delayed absorption) (author's transl)].

1976 • 5 citations

[Experiences with dipropylacetate in the treatment of therapy-resistent adult epileptics].

1974 • 4 citations

[Anticonvulsive therapy using dipropylacetate in children].

1972 • 4 citations

[Depakine in the treatment of essential or idiopathic epilepsy].

1970 • 4 citations

[Clinical observations on the effect of dipropylacetic acid in epileptic and behavioral manifestations].

1970 • 3 citations

[First clinical results of a new anti-epileptic: sodium di-n-propyl acetate (DPA) specialized under the marketed name, Depakine].

1969 • 3 citations

[Results obtained with Depakine in epilepsy resistant to other therapies. Preliminary note].

1969 • 3 citations

[Treatment of epilepsy in children using dipropyl acetic acid (DPA)].

1973 • 3 citations

Progressive myoclonic epilepsy. The response to sodium di -- n -- propylacetate.

1974 • 3 citations

[Depakine (sodium dipropylacetate) in the treatment of epilepsies resistant to other drugs (EEG clinical study in 35 cases followed up for 3-12 months)].

1972 • 2 citations

[Results obtained with DPA at the Hôpital de Jour for epileptic patients in Créteil].

1969 • 2 citations

[Hepatoprotective and hepatoregenerative effects of di-n-propylacetic molecules].

1967 • 2 citations

[Effects of n-dipropylacetic acid (Depakine) on the activity of the cortical epileptic focus produced with cobalt].

1969 • 2 citations

[Clinical evaluation of sodium dipropylacetate (DPA), a new anti-epileptic drug].

1969 • 2 citations

[The Toul-ar-C'Hoat experiment: depakine in the treatment of epileptic children. Longitudinal studies of 74 children].

1970 • 2 citations

[Di-N-propylacetic acid in the epileptic syndrome].

1972 • 2 citations

[Modifications by n-dipropylacetic acid (DPA) sodium salt of the activity of alumina induced cortico-motor epileptogenic foci].

1970 • 2 citations

[Anti-epileptic action of the sodium salt of N-dipropylacetic acid. Experimental study in the cat].

1968 • 2 citations

[Preliminary clinical electroencephalographic study on the treatment of epilepsy with sodium dipropylacetate (Depakine)].

1972 • 1 citations

[Experimental and clinical results of a new anti-epileptic: sodium di-n-propyl acetate (DPA) specialized under the marketed name, Depakine. Second study].

1969 • 1 citations

[Sodium salt of n-dipropylacetic acid or Depakin in the therapy of epilepsy. Preliminary note].

1972 • 1 citations

[Preliminary notes on the clinical use of sodium diproplyacetate (Depakine) in infantile epilepsy].

1973 • 1 citations

Deleted Work

1955 • 0 citations